Thrombocytosis Clinical Trial
Official title:
Molecular Biology of Polycythemia and Thrombocytosis
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
Our hypothesis is that genes and their mutation are causative of certain types of polycythemia and thrombocytosis. These will be sought for by genetic and cell biology means. The purpose of the study is to identify the molecular defect of these disorders. 5-7 teaspoons of peripheral blood will be drawn on all study subjects. After DNA is obtained, linkage analysis and/or mutation analysis will be performed. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02308787 -
Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions
|
N/A | |
| Completed |
NCT01787552 -
A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
|
Phase 1/Phase 2 | |
| Completed |
NCT02125318 -
A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders
|
Phase 2 | |
| Completed |
NCT00509899 -
Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
|
Phase 1/Phase 2 | |
| Terminated |
NCT00882414 -
Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
|
Phase 2 | |
| Recruiting |
NCT03531515 -
Predictors of Reactive Thrombocytosis in Critically Ill Septic Patients
|
||
| Completed |
NCT01194349 -
The Role of Reactive Thrombocytosis in Children With Pneumococcal Infection
|
N/A |